BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 15831607)

  • 21. Relation of ischemia-modified albumin levels and left ventricular systolic function in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Samimi-Fard S; Kaski JC
    Clin Chim Acta; 2008 Feb; 388(1-2):196-9. PubMed ID: 18036561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Armstrong PW; Cannon CP; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2570-89. PubMed ID: 17502591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should primary percutaneous coronary intervention be the preferred method of reperfusion therapy for patients with renal failure and ST-elevation acute myocardial infarction?
    Dragu R; Behar S; Sandach A; Boyko V; Kapeliovich M; Rispler S; Hammerman H
    Am J Cardiol; 2006 Apr; 97(8):1142-5. PubMed ID: 16616015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment and key targets for therapy in the post-myocardial infarction patient with left ventricular dysfunction.
    Flaherty JD; Udelson JE; Gheorghiade M; Wu E; Davidson CJ
    Am J Cardiol; 2008 Sep; 102(5A):5G-12G. PubMed ID: 18722186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative effects of percutaneous coronary intervention for infarct-related artery only or for both infarct- and non-infarct-related arteries in patients with ST-elevation myocardial infarction and multi-vessel disease.
    Han YL; Wang B; Wang XZ; Li Y; Wang SL; Jing QM; Wang G; Ma YY; Luan B
    Chin Med J (Engl); 2008 Dec; 121(23):2384-7. PubMed ID: 19102953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of left ventricular dyssynchrony after acute myocardial infarction, assessed by a tagging magnetic resonance image derived metric, as a determinant of ventricular remodeling.
    Chang SA; Chang HJ; Choi SI; Chun EJ; Yoon YE; Kim HK; Kim YJ; Choi DJ; Sohn DW; Helm RH; Lardo AC
    Am J Cardiol; 2009 Jul; 104(1):19-23. PubMed ID: 19576315
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ST-segment resolution assessed immediately after primary percutaneous coronary intervention correlates with infarct size and left ventricular function in cardiac magnetic resonance at 1-year follow-up.
    Rakowski T; Dziewierz A; Siudak Z; Mielecki W; Brzozowska-Czarnek A; Legutko J; Rzeszutko L; Urbanik A; Dubiel JS; Dudek D
    J Electrocardiol; 2009; 42(2):152-6. PubMed ID: 19167012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of late survival in patients with cardiogenic shock due to right ventricular infarction versus left ventricular pump failure following primary percutaneous coronary intervention for ST-elevation acute myocardial infarction.
    Brodie BR; Stuckey TD; Hansen C; Bradshaw BH; Downey WE; Pulsipher MW
    Am J Cardiol; 2007 Feb; 99(4):431-5. PubMed ID: 17293178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathophysiology of heart failure following myocardial infarction.
    Struthers AD
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii14-6; discussion ii31, ii43-8. PubMed ID: 15831601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac troponin I for the prediction of functional recovery and left ventricular remodelling following primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Hallén J; Jensen JK; Fagerland MW; Jaffe AS; Atar D
    Heart; 2010 Dec; 96(23):1892-7. PubMed ID: 21062778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
    White HD; Aylward PE; Huang Z; Dalby AJ; Weaver WD; Barvik S; Marin-Neto JA; Murin J; Nordlander RO; van Gilst WH; Zannad F; McMurray JJ; Califf RM; Pfeffer MA;
    Circulation; 2005 Nov; 112(22):3391-9. PubMed ID: 16301343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).
    Marso SP; Miller T; Rutherford BD; Gibbons RJ; Qureshi M; Kalynych A; Turco M; Schultheiss HP; Mehran R; Krucoff MW; Lansky AJ; Stone GW
    Am J Cardiol; 2007 Jul; 100(2):206-10. PubMed ID: 17631071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials.
    De Luca G; Biondi-Zoccai G; Marino P
    Ann Emerg Med; 2008 Dec; 52(6):665-76. PubMed ID: 19027496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of thrombolysis followed by broad use of percutaneous coronary intervention with primary percutaneous coronary intervention for ST-segment-elevation acute myocardial infarction: data from the french registry on acute ST-elevation myocardial infarction (FAST-MI).
    Danchin N; Coste P; Ferrières J; Steg PG; Cottin Y; Blanchard D; Belle L; Ritz B; Kirkorian G; Angioi M; Sans P; Charbonnier B; Eltchaninoff H; Guéret P; Khalife K; Asseman P; Puel J; Goldstein P; Cambou JP; Simon T;
    Circulation; 2008 Jul; 118(3):268-76. PubMed ID: 18591434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.
    Atar D; Petzelbauer P; Schwitter J; Huber K; Rensing B; Kasprzak JD; Butter C; Grip L; Hansen PR; Süselbeck T; Clemmensen PM; Marin-Galiano M; Geudelin B; Buser PT;
    J Am Coll Cardiol; 2009 Feb; 53(8):720-9. PubMed ID: 19232907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
    Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
    Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prophylactic intraaortic balloon pumping preserves left ventricular systolic function in acute anterior myocardial infarction without cardiogenic shock].
    Niida T; Sakuma T; Motoda C; Tokuyama T; Oka T; Okada T; Otsuka M; Toyofuku M; Hirao H; Muraoka Y; Ueda H; Masaoka Y; Hayashi Y
    J Cardiol; 2006 Nov; 48(5):243-51. PubMed ID: 17136819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
    Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The chemokine network in relation to infarct size and left ventricular remodeling following acute myocardial infarction.
    Orn S; Breland UM; Mollnes TE; Manhenke C; Dickstein K; Aukrust P; Ueland T
    Am J Cardiol; 2009 Nov; 104(9):1179-83. PubMed ID: 19840558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.